People who are taking common cardiovascular drugs and given Paxlovid (nirmatrelvir/ritonavir) are at risk of drug-drug interactions, according to a review in the Journal of the American College of Cardiology.
Just over 60% of seniors living in long-term care were prescribed antidepressants in 2017, data analyzed by the institute indicates. That rose to 62% of residents by 2019 and 65% in 2021.